• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
PGx Testing: First, Do No Harm

PGx Testing: First, Do No Harm

by Michael Schubert, PhD | Sep 20, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
At-Home Genetic Testing: The Good, The Bad, and The Ugly

At-Home Genetic Testing: The Good, The Bad, and The Ugly

by Liv Gaskill, MSc | Sep 5, 2024 | Essential, Industry Buzz-lir, Lab Industry Advisor, Legislation-lca

Direct-to-consumer (DTC) genetic testing has risen in popularity in recent years—but is it all it’s cracked up to be?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Laboratory Genetic Counselors: A Valuable Investment

Laboratory Genetic Counselors: A Valuable Investment

by Michael Schubert, PhD | Sep 5, 2024 | Essential, Inside the Lab Industry-lir, Lab Industry Advisor

As the field of genetic testing grows, genetic counselors can help labs meet patients’ needs and keep up with new developments

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Private Payer Reimbursement for Genetic Testing Hinges on Clinical Utility

Private Payer Reimbursement for Genetic Testing Hinges on Clinical Utility

by Tara Cepull, MA | Sep 3, 2024 | Essential, Lab Industry Advisor, Reimbursement-lca

Two revenue cycle management experts offer tips for clinical labs to improve coverage decisions for genetic tests

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: Scientists Ask Agency to Rescind Approval for Opioid Management Test

Diagnostics Pipeline: Scientists Ask Agency to Rescind Approval for Opioid Management Test

by Ron Shinkman | Aug 30, 2024 | Clinical Diagnostics Insider, FDA-dtet

Experts—including those in genetics and device regulation—say the AvertD assay did not predict risks of abuse ‘any better than chance’

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com